Last reviewed · How we verify

NCT04789369

Fear of Movement, Functionality and Quality of Life in Elite Athletes With an Ankle Instability History

Completed Last updated 3 June 2022
What this trial tests

trial testing Questionnaires in Ankle Sprains in 80 participants. Completed in 30 May 2022.

Timeline
15 March 2021
Primary endpoint
15 May 2022
30 May 2022

Quick facts

Lead sponsorAcibadem University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date15 March 2021
Primary completion15 May 2022
Estimated completion30 May 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Acibadem University

Who can join

Adults 18 to 35, any sex, with Ankle Sprains. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ankle sprain is frequently experienced by individuals participating in different sports activities. Ankle sprains have been shown to result in a decrease in level of physical activity and persistence of some symptoms for a long time. In this case, it is predicted that ankle sprains may affect the quality of life as well as functionality. Also, ankle sprain history may result in increased fear of movement, which may delay return to sports. This study aimed to examine the relationship between foot and ankle functionality, fear of movement and quality of life of elite athletes with a history of ankle sprain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other recruiting trials for Ankle Sprains

Currently open trials in the same condition.

Other Acibadem University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04789369.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing